PUBLICATION
            How activating mutations affect MEK1 regulation and function
- Authors
- Jindal, G.A., Goyal, Y., Humphreys, J.M., Yeung, E., Tian, K., Patterson, V.L., He, H., Burdine, R.D., Shvartsman, S.Y., Goldsmith, E.J.
- ID
- ZDB-PUB-171012-3
- Date
- 2017
- Source
- The Journal of biological chemistry 292(46): 18814-18820 (Journal)
- Registered Authors
- Burdine, Rebecca
- Keywords
- MEK1, Raf kinase, cancer biology, mitogen-activated protein kinase (MAPK), protein phosphorylation, zebrafish
- MeSH Terms
- 
    
        
        
            
                - Phosphorylation
- Protein Conformation
- Crystallography, X-Ray
- Animals
- Point Mutation*
- Enzyme Activation
- Humans
- MAP Kinase Kinase 1/chemistry
- MAP Kinase Kinase 1/genetics*
- MAP Kinase Kinase 1/metabolism*
- Models, Molecular
- Zebrafish
- raf Kinases/metabolism
- Mitogen-Activated Protein Kinase 1/metabolism
- Neoplasms/genetics
- Neoplasms/metabolism
 
- PubMed
- 29018093 Full text @ J. Biol. Chem.
            Citation
        
        
            Jindal, G.A., Goyal, Y., Humphreys, J.M., Yeung, E., Tian, K., Patterson, V.L., He, H., Burdine, R.D., Shvartsman, S.Y., Goldsmith, E.J. (2017) How activating mutations affect MEK1 regulation and function. The Journal of biological chemistry. 292(46):18814-18820.
        
    
                
                    
                        Abstract
                    
                    
                
                
            
        
        
    
        
            
            
 
    
    
        
    
    
    
        
                The MEK1 kinase directly phosphorylates ERK2, after the activation loop of MEK1 is itself phosphorylated by Raf. Studies over the past decade have revealed a large number of disease-related mutations in the MEK1 gene that lead to tumorigenesis and abnormal development. Several of these mutations result in MEK1 constitutive activity, but how they affect MEK1 regulation and function remains largely unknown. Here, we address these questions focusing on two pathogenic variants of the Phe-53 residue, which maps to the well-characterized negative regulatory region of MEK1. We found that these variants are phosphorylated by Raf faster than the wild-type enzyme, and this phosphorylation further increases their enzymatic activity. However, the maximal activities of fully phosphorylated wild-type and mutant enzymes are indistinguishable. On the basis of available structural information, we propose that the activating substitutions destabilize the inactive conformation of MEK1, resulting in its constitutive activity and making it more prone to Raf-mediated phosphorylation. Experiments in zebrafish revealed that the effects of activating variants on embryonic development reflect the joint control of the negative regulatory region and activating phosphorylation. Our results underscore the complexity of the effects of activating mutations on signaling systems, even at the level of a single protein.
            
    
        
        
    
    
    
                
                    
                        Genes / Markers
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Expression
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Phenotype
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mutations / Transgenics
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Human Disease / Model
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Sequence Targeting Reagents
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Fish
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Orthology
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Engineered Foreign Genes
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    
                
                    
                        Mapping
                    
                    
                
                
            
        
        
    
        
            
            
        
        
    
    
    